Vivos Therapeutics Acquires Nevada Sleep Center's Operations for up to $9 Million

Summary

Vivos Therapeutics (VVOS) has signed a definitive agreement to acquire the operational assets of the Nevada Sleep Center for up to $9 million. The transaction includes $6 million in cash and $1.5 million in Vivos common stock at closing, with an additional $1.5 million contingent on future financial milestones. The Sleep Center provides services related to sleep disorders to approximately 3,000 new patients monthly. rttnews

Impact Analysis

The acquisition of Nevada Sleep Center is a strategic move by Vivos Therapeutics aimed at expanding its presence in the sleep disorder treatment market. This aligns with Vivos’ broader strategy to enhance its marketing and distribution model through strategic alliances and acquisitions, highlighted in previous discussions about partnerships with sleep centers like Rebis Health. The acquisition provides Vivos with access to a large patient base, potentially increasing revenue from new obstructive sleep apnea (OSA) diagnoses, with expected revenue per case significantly boosting profit margins.Baystreet+ 2 The acquisition is likely to support Vivos’ growth prospects, as evidenced by recent revenue growth and strategic shifts in business models. However, risks involve integration challenges and maintaining the profitability of acquired assets while navigating competitive pressures in the healthcare sector.Reuters+ 2